MS groups launch coronavirus and MS reporting database

April 10, 2020
The Consortium of Multiple Sclerosis Centers and the National Multiple Sclerosis Society have joined forces to create COViMS, a new North American database to capture COVID-19 infections in people with MS. This effort will capture information on outcomes of people with MS who have developed COVID-19.

There is an unmet need to understand the effects of SARS-CoV-2 infection on the health and wellness of people living with MS. Up to now, there is no reporting system organized in North America to collect data that can track the outcomes and potentially inform treatment of people with MS infected with this coronavirus (or other similar future virus infections). The goal of the COViMS registry is to rapidly define the effect of COVID-19 on patients with MS and how factors such as age, comorbidities, and MS treatments affect COVID outcomes.

Healthcare providers taking care of patients with MS and documented COVID-19 are encouraged to complete a Case Report Form on the COViMS website. The COViMS website also has FAQs, a sample CRF, resources and will provide real time data once registry participation is underway.

To obtain additional information about this joint effort or to report a case of COVID-19, please visit

MS Focus Lending Library

Books, DVDs, and CDs are available for loan, by mail across the United States.
Learn more